Chondrosarcomas revisited

Andreas F. Mavrogenis, Marco Gambaroti, Andrea Angelini, Emanuela Palmerini, Eric L. Staals, Pietro Ruggieri, Panayiotis J. Papagelopoulos

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Chondrosarcomas are malignant bone tumors with pure hyaline cartilage differentiation; myxoid changes, calcification, or ossification may be present. Several subtypes of chondrosarcomas exist. Behavior patterns vary, ranging from slow-growing nonmetastasizing lesions to aggressive metastasizing sarcomas. Symptoms are usually mild, with duration ranging from several months to years, and usually consist of persistent, dull, aching pain or palpable masses. Radiographic findings include bone expansion with cortical thickening, radiolucent areas with variably distributed punctate or ring-like matrix calcifications, cortical erosion or destruction, endosteal scalloping, and scant or absent periosteal reaction; extension into the soft tissue may be present. Histological differential diagnosis from benign cartilaginous lesions can be achieved by increased cellularity, enlarged plump nuclei, binucleated cells, hyperchromatic nuclear pleomorphism, and permeation of cortical or medullary bone. Atypia is usually mild to moderate; necrosis and mitoses can be seen, particularly in high-grade lesions. Adequate surgery is the mainstay of treatment. High-grade and pelvic chondrosarcomas are best managed with wide resection. Because of the low metastatic potential and low local recurrence rate noted with intralesional surgery, low-grade chondrosarcomas can be treated with curettage (with or without treatment of the defect cavity) with a local adjuvant, such as phenol or cryotherapy. Adjuvant chemotherapy may be considered for mesenchymal and dedifferentiated chondrosarcomas. Radiation therapy can be considered after incomplete resection or if resection is not feasible or would cause unacceptable morbidity.

Original languageEnglish
JournalOrthopedics
Volume35
Issue number3
DOIs
Publication statusPublished - Mar 2012

Fingerprint

Chondrosarcoma
Bone and Bones
Mesenchymal Chondrosarcoma
Hyaline Cartilage
Cryotherapy
Curettage
Adjuvant Chemotherapy
Phenol
Cell Nucleus
Mitosis
Osteogenesis
Sarcoma
Differential Diagnosis
Necrosis
Radiotherapy
Morbidity
Recurrence
Pain
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Mavrogenis, A. F., Gambaroti, M., Angelini, A., Palmerini, E., Staals, E. L., Ruggieri, P., & Papagelopoulos, P. J. (2012). Chondrosarcomas revisited. Orthopedics, 35(3). https://doi.org/10.3928/01477447-20120222-30

Chondrosarcomas revisited. / Mavrogenis, Andreas F.; Gambaroti, Marco; Angelini, Andrea; Palmerini, Emanuela; Staals, Eric L.; Ruggieri, Pietro; Papagelopoulos, Panayiotis J.

In: Orthopedics, Vol. 35, No. 3, 03.2012.

Research output: Contribution to journalArticle

Mavrogenis, AF, Gambaroti, M, Angelini, A, Palmerini, E, Staals, EL, Ruggieri, P & Papagelopoulos, PJ 2012, 'Chondrosarcomas revisited', Orthopedics, vol. 35, no. 3. https://doi.org/10.3928/01477447-20120222-30
Mavrogenis AF, Gambaroti M, Angelini A, Palmerini E, Staals EL, Ruggieri P et al. Chondrosarcomas revisited. Orthopedics. 2012 Mar;35(3). https://doi.org/10.3928/01477447-20120222-30
Mavrogenis, Andreas F. ; Gambaroti, Marco ; Angelini, Andrea ; Palmerini, Emanuela ; Staals, Eric L. ; Ruggieri, Pietro ; Papagelopoulos, Panayiotis J. / Chondrosarcomas revisited. In: Orthopedics. 2012 ; Vol. 35, No. 3.
@article{6aebf0d3958f47b2aa7206f23390d179,
title = "Chondrosarcomas revisited",
abstract = "Chondrosarcomas are malignant bone tumors with pure hyaline cartilage differentiation; myxoid changes, calcification, or ossification may be present. Several subtypes of chondrosarcomas exist. Behavior patterns vary, ranging from slow-growing nonmetastasizing lesions to aggressive metastasizing sarcomas. Symptoms are usually mild, with duration ranging from several months to years, and usually consist of persistent, dull, aching pain or palpable masses. Radiographic findings include bone expansion with cortical thickening, radiolucent areas with variably distributed punctate or ring-like matrix calcifications, cortical erosion or destruction, endosteal scalloping, and scant or absent periosteal reaction; extension into the soft tissue may be present. Histological differential diagnosis from benign cartilaginous lesions can be achieved by increased cellularity, enlarged plump nuclei, binucleated cells, hyperchromatic nuclear pleomorphism, and permeation of cortical or medullary bone. Atypia is usually mild to moderate; necrosis and mitoses can be seen, particularly in high-grade lesions. Adequate surgery is the mainstay of treatment. High-grade and pelvic chondrosarcomas are best managed with wide resection. Because of the low metastatic potential and low local recurrence rate noted with intralesional surgery, low-grade chondrosarcomas can be treated with curettage (with or without treatment of the defect cavity) with a local adjuvant, such as phenol or cryotherapy. Adjuvant chemotherapy may be considered for mesenchymal and dedifferentiated chondrosarcomas. Radiation therapy can be considered after incomplete resection or if resection is not feasible or would cause unacceptable morbidity.",
author = "Mavrogenis, {Andreas F.} and Marco Gambaroti and Andrea Angelini and Emanuela Palmerini and Staals, {Eric L.} and Pietro Ruggieri and Papagelopoulos, {Panayiotis J.}",
year = "2012",
month = "3",
doi = "10.3928/01477447-20120222-30",
language = "English",
volume = "35",
journal = "Orthopedics",
issn = "0147-7447",
publisher = "Slack Incorporated",
number = "3",

}

TY - JOUR

T1 - Chondrosarcomas revisited

AU - Mavrogenis, Andreas F.

AU - Gambaroti, Marco

AU - Angelini, Andrea

AU - Palmerini, Emanuela

AU - Staals, Eric L.

AU - Ruggieri, Pietro

AU - Papagelopoulos, Panayiotis J.

PY - 2012/3

Y1 - 2012/3

N2 - Chondrosarcomas are malignant bone tumors with pure hyaline cartilage differentiation; myxoid changes, calcification, or ossification may be present. Several subtypes of chondrosarcomas exist. Behavior patterns vary, ranging from slow-growing nonmetastasizing lesions to aggressive metastasizing sarcomas. Symptoms are usually mild, with duration ranging from several months to years, and usually consist of persistent, dull, aching pain or palpable masses. Radiographic findings include bone expansion with cortical thickening, radiolucent areas with variably distributed punctate or ring-like matrix calcifications, cortical erosion or destruction, endosteal scalloping, and scant or absent periosteal reaction; extension into the soft tissue may be present. Histological differential diagnosis from benign cartilaginous lesions can be achieved by increased cellularity, enlarged plump nuclei, binucleated cells, hyperchromatic nuclear pleomorphism, and permeation of cortical or medullary bone. Atypia is usually mild to moderate; necrosis and mitoses can be seen, particularly in high-grade lesions. Adequate surgery is the mainstay of treatment. High-grade and pelvic chondrosarcomas are best managed with wide resection. Because of the low metastatic potential and low local recurrence rate noted with intralesional surgery, low-grade chondrosarcomas can be treated with curettage (with or without treatment of the defect cavity) with a local adjuvant, such as phenol or cryotherapy. Adjuvant chemotherapy may be considered for mesenchymal and dedifferentiated chondrosarcomas. Radiation therapy can be considered after incomplete resection or if resection is not feasible or would cause unacceptable morbidity.

AB - Chondrosarcomas are malignant bone tumors with pure hyaline cartilage differentiation; myxoid changes, calcification, or ossification may be present. Several subtypes of chondrosarcomas exist. Behavior patterns vary, ranging from slow-growing nonmetastasizing lesions to aggressive metastasizing sarcomas. Symptoms are usually mild, with duration ranging from several months to years, and usually consist of persistent, dull, aching pain or palpable masses. Radiographic findings include bone expansion with cortical thickening, radiolucent areas with variably distributed punctate or ring-like matrix calcifications, cortical erosion or destruction, endosteal scalloping, and scant or absent periosteal reaction; extension into the soft tissue may be present. Histological differential diagnosis from benign cartilaginous lesions can be achieved by increased cellularity, enlarged plump nuclei, binucleated cells, hyperchromatic nuclear pleomorphism, and permeation of cortical or medullary bone. Atypia is usually mild to moderate; necrosis and mitoses can be seen, particularly in high-grade lesions. Adequate surgery is the mainstay of treatment. High-grade and pelvic chondrosarcomas are best managed with wide resection. Because of the low metastatic potential and low local recurrence rate noted with intralesional surgery, low-grade chondrosarcomas can be treated with curettage (with or without treatment of the defect cavity) with a local adjuvant, such as phenol or cryotherapy. Adjuvant chemotherapy may be considered for mesenchymal and dedifferentiated chondrosarcomas. Radiation therapy can be considered after incomplete resection or if resection is not feasible or would cause unacceptable morbidity.

UR - http://www.scopus.com/inward/record.url?scp=84858640801&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858640801&partnerID=8YFLogxK

U2 - 10.3928/01477447-20120222-30

DO - 10.3928/01477447-20120222-30

M3 - Article

C2 - 22385450

AN - SCOPUS:84858640801

VL - 35

JO - Orthopedics

JF - Orthopedics

SN - 0147-7447

IS - 3

ER -